Evidence map›Paper›PMID 38149663›Full record

ArticleJournal of cell science2024

Microtubule association of TRIM3 revealed by differential extraction proteomics.

Hannah L Glover, Marta Mendes, Joana Gomes-Neto, Emma V Rusilowicz-Jones, Daniel J Rigden, Gunnar Dittmar, Sylvie Urbé, Michael J Clague

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Hannah L GloverDepartment of Biochemistry, Cell and Systems Biology, ISMIB, University of Liverpool, Liverpool L69 3BX, UK.ORCID 0000-0003-3809-9977
Marta MendesProteomics of Cellular Signalling, Department of Infection and Immunity, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg.
Joana Gomes-NetoDepartment of Biochemistry, Cell and Systems Biology, ISMIB, University of Liverpool, Liverpool L69 3BX, UK.ORCID 0000-0002-0105-8699
Emma V Rusilowicz-JonesDepartment of Biochemistry, Cell and Systems Biology, ISMIB, University of Liverpool, Liverpool L69 3BX, UK.ORCID 0000-0001-7496-3318
Daniel J RigdenDepartment of Biochemistry, Cell and Systems Biology, ISMIB, University of Liverpool, Liverpool L69 3BX, UK.ORCID 0000-0002-7565-8937
Gunnar DittmarProteomics of Cellular Signalling, Department of Infection and Immunity, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg.ORCID 0000-0003-3647-8623
Sylvie UrbéDepartment of Biochemistry, Cell and Systems Biology, ISMIB, University of Liverpool, Liverpool L69 3BX, UK.ORCID 0000-0003-4735-9814
Michael J ClagueDepartment of Biochemistry, Cell and Systems Biology, ISMIB, University of Liverpool, Liverpool L69 3BX, UK.ORCID 0000-0003-3355-9479
University of Liverpool · GBLuxembourg Institute of Health · LUUniversity of Luxembourg · LU

Funding

Wellcome Trust
6 · The paper itself

Abstract

The microtubule network is formed from polymerised tubulin subunits and associating proteins, which govern microtubule dynamics and a diverse array of functions. To identify novel microtubule-binding proteins, we have developed an unbiased biochemical assay, which relies on the selective extraction of cytosolic proteins from U2OS cells, while leaving behind the microtubule network. Candidate proteins are linked to microtubules by their sensitivities to the depolymerising drug nocodazole or the microtubule-stabilising drug taxol, which is quantitated by mass spectrometry. Our approach is benchmarked by co-segregation of tubulin and previously established microtubule-binding proteins. We then identify several novel candidate microtubule-binding proteins, from which we have selected the ubiquitin E3 ligase tripartite motif-containing protein 3 (TRIM3) for further characterisation. We map TRIM3 microtubule binding to its C-terminal NHL-repeat region. We show that TRIM3 is required for the accumulation of acetylated tubulin, following treatment with taxol. Furthermore, loss of TRIM3 partially recapitulates the reduction in nocodazole-resistant microtubules characteristic of α-tubulin acetyltransferase 1 (ATAT1) depletion. These results can be explained by a decrease in ATAT1 following depletion of TRIM3 that is independent of transcription.

Indexed as

ProteomicsTubulinCarrier ProteinsMicrotubulesNocodazolePaclitaxelProteinsCarrier ProteinsNocodazolePaclitaxelProteinsTubulinLGALSLMicrotubulesNocodazoleProteomicsTaxolTRIM

Identifiers

PMID38149663
PMCPMC10917062
OpenAlexW4390273804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.